WHEREAS, October 8-14, 2017 marks Plasma Awareness Week with observances throughout the United States designed to raise awareness of the importance of plasma donation. During this week we see its impact on patients with rare diseases, recognize the contributions of plasma donors to saving and improving lives and strive to increase understanding of life-saving plasma protein therapies and the conditions they treat; and,
WHEREAS, plasma-derived and recombinant therapies, collectively known as plasma protein therapies, are unique, biologic products for which no substitutes exist. They save and improve the lives of individuals throughout the world; and,
WHEREAS, plasma protein therapies are used to treat many conditions including hemophilia and other bleeding disorders, primary immune deficiencies, alpha-1 antitrypsin deficiency, hereditary angioedema, chronic inflammatory demyelinating polyneuropathy, idiopathic thrombocytopenic purpura, and Rh negative pregnancies; and,
WHEREAS, these therapies substantially increase quality of life, extend life expectancy and improve patient outcomes for thousands of individuals in the state of Michigan; and,
WHEREAS, each year thousands of pregnant women in Michigan receive plasma protein therapy to protect from complications due to incompatible blood types; and,
WHEREAS, there are 21 plasma donation centers in Michigan certified under the International Quality Plasma Program where healthy and committed donors provide plasma that is used to manufacture high-impact, life-saving therapies;
NOW, THEREFORE, I, Rick Snyder, governor of Michigan, do hereby proclaim October 8-14, 2017 as Plasma Awareness Week in Michigan.